【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Breakthrough in asthma research
• Asthma: An overview
PART 05: Pipeline portfolio
PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 07: Key buying criteria for asthma drugs
PART 08: Market segmentation by type of treatment
• Preventive medications
• Quick-relief medications
• Others
PART 09: Market segmentation by drug class
• Combination therapies
• Bronchodilators
• Immunosuppressants
• Leukotriene antagonists
• Mast cell stabilizers
PART 10: Segmentation by route of administration
• Inhalation
• Parenteral
• Oral
PART 11: Drug delivery devices market for asthma drugs
• Market overview
• Market segmentation by product type
PART 12: Geographical segmentation
• Global asthma therapeutics market by geography 2015-2020
• Asthma therapeutics market in Americas
• Asthma therapeutics market in EMEA
• Asthma therapeutics market in APAC
PART 13: Market drivers
• Huge market potential for mAbs
• New product approvals minimizing the impact of generic erosion
• Increasing rate of allergies due to environmental pollution
PART 14: Impact of drivers
PART 15: Market challenges
• Increased preference for CAM
• Poor patient adherence toward controller medications
• Presence of different phenotypes of asthma leading to prescription errors
PART 16: Impact of drivers and challenges
PART 17: Market trends
• Innovative technologies for drug delivery
• Growing adoption of immunotherapies
• Shift toward immune/inflammatory system targets from glucocorticoid and adrenergic receptors
• Increase in online marketing services
• Growing use of home healthcare devices
PART 18: Vendor landscape
• Competitive scenario
• Key news
PART 19: Key vendor analysis
• AstraZeneca
• Boehringer Ingelheim
• F. Hoffmann-La Roche
• GSK
• Merck
• Other prominent vendors
PART 20: Appendix
• List of abbreviations
PART 21: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Breakthrough in asthma research
Exhibit 03: Major diagnostic procedures for asthma
Exhibit 04: Percentage share of pipeline molecules based on stage of development
Exhibit 05: Pipeline portfolio: Global asthma therapeutics market
Exhibit 06: Global asthma drugs market: Market overview 2015
Exhibit 07: Global asthma therapeutics market 2015-2020 ($ billions)
Exhibit 08: Global asthma drugs market snapshot: Developed and emerging markets 2015
Exhibit 09: Global asthma therapeutics market: Key parameters driving the market growth 2015
Exhibit 10: Five forces analysis
Exhibit 11: Key buying criteria for asthma drugs
Exhibit 12: Global asthma therapeutics market: Key parameters importance
Exhibit 13: Impact of key customer segments on market
Exhibit 14: Segmentation of asthma drugs based on type of treatment
Exhibit 15: Segmentation of asthma drugs based on drug class
Exhibit 16: Percentage share of global asthma therapeutics by drug class based on revenue 2015
Exhibit 17: Global asthma therapeutics market: Drug class segmentation growth cycle analysis 2015
Exhibit 18: Combination therapies market in global asthma therapeutics market 2015-2020 ($ billions)
Exhibit 19: Bronchodilators market in global asthma therapeutics market 2015-2020 ($ billions)
Exhibit 20: Percentage share of allergy immunotherapies and steroids in global immunosuppressants market 2015
Exhibit 21: Immunosuppressants market in global asthma therapeutics market 2015-2020 ($ billions)
Exhibit 22: Leukotriene antagonists market in global asthma therapeutics market 2015-2020 ($ billions)
Exhibit 23: Mast cell stabilizers market in global asthma therapeutics market 2015-2020 ($ billions)
Exhibit 24: Segmentation of global asthma therapeutics market by route of administration
Exhibit 25: Global asthma drug delivery devices market 2015-2020 ($ millions)
Exhibit 26: Global asthma drug delivery devices market segmentation by product type
Exhibit 27: Percentage share of global asthma drug delivery devices by type 2015
Exhibit 28: Percentage share of inhalers in global asthma drug delivery devices market 2015
Exhibit 29: Inhalers market in global asthma drug-delivery devices market 2015-2020 ($ millions)
Exhibit 30: Percentage share of nebulizers in global asthma drug delivery devices market 2015
Exhibit 31: Nebulizers market in global asthma drug-delivery devices market 2015-2020 ($ millions)
Exhibit 32: Global asthma therapeutics market by geography 2015-2020
Exhibit 33: Percentage share of global asthma therapeutics market by geography 2015 and 2020
Exhibit 34: Global asthma therapeutics market segmentation by geography 2015-2020 ($ billions)
Exhibit 35: Global share of asthma therapeutics market by geography 2015
Exhibit 36: Global asthma therapeutics market: Country analysis based on revenue and growth rate
Exhibit 37: Impact of ACA act on asthma therapeutics market
Exhibit 38: Asthma therapeutics market in Americas 2015-2020 ($ billions)
Exhibit 39: Asthma therapeutics market: PEST analysis
Exhibit 40: Prevalence of asthma in major countries of EMEA
Exhibit 41: Asthma therapeutics market in EMEA 2015-2020 ($ billions)
Exhibit 42: Asthma therapeutics market in EMEA: PEST analysis
Exhibit 43: Asthma therapeutics market in APAC 2015-2020 ($ billions)
Exhibit 44: Asthma therapeutics market: PEST analysis
Exhibit 45: mAbs approved for treatment of asthma
Exhibit 46: mAbs under development for treatment of asthma
Exhibit 47: Impact of drivers
Exhibit 48: Use of CAM therapies among individuals in US
Exhibit 49: Impact of drivers and challenges
Exhibit 50: Market share of major vendors based on asthma therapeutics revenue 2015
Exhibit 51: Competitive scenario of global asthma therapeutics market vendors 2015-2020
Exhibit 52: Geographical presence of key vendors
Exhibit 53: AstraZeneca: YoY revenue and growth rate of Symbicort 2013-2015 ($ billions)
Exhibit 54: AstraZeneca: Geographical segmentation of Symbicort 2015
Exhibit 55: AstraZeneca: YoY revenue and growth rate of Pulmicort 2013-2015 ($ millions)
Exhibit 56: AstraZeneca: Geographic segmentation of Pulmicort 2015
Exhibit 57: AstraZeneca: Metrics analysis
Exhibit 58: Boehringer Ingelheim: YoY revenue and growth rate of Spiriva 2013-2015 ($ billions)
Exhibit 59: Boehringer Ingelheim: Metrics analysis
Exhibit 60: F. Hoffmann-La Roche: YoY revenue and growth rate of Xolair 2012-2014 ($ millions)
Exhibit 61: F. Hoffmann-La Roche: Metrics analysis
Exhibit 62: GSK: YoY revenue and growth rate of Seretide/Advair 2013-2015 ($ billions)
Exhibit 63: Geographical segmentation of Seretide/Advair 2015
Exhibit 64: GSK: YoY revenue and growth rate of Flixotide/Flovent 2013-2015 ($ billions)
Exhibit 65: GSK: Geographical segmentation of Flixotide/Flovent 2015
Exhibit 66: GSK: YoY revenue and growth rate of Ventolin 2013-2015 ($ billions)
Exhibit 67: GSK: Geographical segmentation of Ventolin 2015
Exhibit 68: GSK: YoY growth and revenue of Relvar/Breo Ellipta 2014-2015 ($ millions)
Exhibit 69: GSK: Geographical segmentation of Relvar/Breo Ellipta 2015
Exhibit 70: GSK: Metrics analysis
Exhibit 71: Merck: YoY growth and revenue of Singulair 2013-2015 ($ millions)
Exhibit 72: Merck: YoY growth and revenue of Dulera 2013-2015 ($ millions)
Exhibit 73: Merck: Metrics analysis0
【レポート販売概要】
■ タイトル：喘息治療薬の世界市場2016-2020■ 英文：Global Asthma Therapeutics Market 2016-2020
■ 発行日：2016年7月27日
■ 調査会社：Technavio
■ 商品コード：IRTNTR10076
■ 調査対象地域：グローバル
- 世界の物理セキュリティー市場：ビデオ監視、アクセスコントロール、生体認証、侵入検知、セキュリティシステムなどThe security concerns for personnel, information, hardware, and network infrastructure increased the demand for innovative physical security products. The adoption of Internet Protocol (IP) video network, sophisticated access control systems and monitoring solutions, such as Physical Security Information Management (PSIM) will drive the market in the near future. The demand is huge in the emerging …
- 皮膚T細胞リンパ腫：世界の臨床試験レビュー（2014年上半期）Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2014" provides data on the Cutaneous T-Cell Lymphoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cutaneous T-Cell Lymphoma. It includes an overview of the trial …
- 世界における非侵襲性血圧モニターの製品パイプライン動向2015Non-Invasive Blood Pressure Monitors - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Non-Invasive Blood Pressure Monitors - Pipeline Review, 2015" provides an overview of Non-Invasive Blood Pressure Monitors currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of …
- 流体処理装置・消耗品の世界市場：ポンプ、バルブ、液体処理、空気・ガス処理About Global Fluid Treatment market The Global Fluid Treatment market is growing steadily and is driven by various industrial segment. Many manufacturing industries worldwide, which comes under the Industrial segment, need fluid treatment equipment and consumables to control and manage the flow of water and air in their manufacturing plants. Thus, the Global Fluid Treatment market includes equipme …
- J.M. Huber Corporation：石油・ガスバリューチェーン分析レポート2013J.M. Huber Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "J.M. Huber Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “J.M. Huber Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The repor …
- 二輪車用スリッパークラッチの世界市場2016-2020About Global Slipper Clutch Market The growth of the slipper clutch market is directly proportional to the growth of the premium motorcycle market; the former is a derived market because its growth or decline depends on the number of premium motorcycle units sold. Currently, this study focuses on the factory set slipper clutches. Hence the OEM segment would contribute to the overall market scope t …
- マイクログリッドの世界市場：グリッドコネクテッド型、リモート/アイランド型、ハイブリッド型The microgrid market is estimated to reach USD 34.94 Billion by 2022, at a CAGR of 10.9% between 2016 and 2022. Growing demand for scalable and economic grid controls, cheap and clean energy storage options, and shift towards remote grids in the military segment are the factors driving the microgrid market positively. Among the grid-types available, remote grid-type is expected to grow at the high …
- 世界のモバイルM2Mモジュール市場（2014-2018）TechNavio's analysts forecast the Global Mobile M2M Module market to grow at a CAGR of 16.21 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing adoption of mobile devices. The Global Mobile M2M Module market has also been witnessing the decreasing average selling price of mobile M2M modules. However, the dependency on the deployment of wi …
- 患者ポータルの世界市場予測（～2020）The global patient portal market is segmented on the basis of type, delivery mode, and end user. The market is expected to reach USD 2.74 Billion in 2020 from USD 1.19 Billion in 2015, growing at a CAGR of 18.1%. The market is expected to be dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). The European region is expected to grow at the highest rate dur …
- Saudi ArabiaのSodium Triphosphate (Sodium Tripolyphosphate)市場：貿易（輸入、輸出）動向This market research report examines the foreign trade of Saudi Arabia and its perspectives on the global market for sodium triphosphate (sodium tripolyphosphate). The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on sodium triphosphate (sodium tripolyphosphate) export/imp …
- 船舶用エンジン監視システムの世界市場2019-2023About this market The global naval market is growth in investment in auxiliaries such as oilers and supply ships to support the naval fleet in long-range operations of a country. The growth of naval capabilities will result in the growth of automation, cybersecurity, sensor integration, and related technologies. Therefore, the growth of the naval market in developed countries and emerging economie …
- 神経修復・神経再生の世界市場：生体材料、神経管、神経プロテクター、神経ラップ、デバイスThe global nerve repair and regeneration market is expected to reach USD 10,398.79 million by 2020 from USD 5,945.69 million in 2015 at a CAGR of 11.83%. Nerve injuries are most common in the upper (hand and arm) and lower (leg) extremities. Nerve damages can be caused by either blunt trauma, such as an impact from a fall or from traction injuries from motor vehicle accidents, or sharp trauma, suc …
- Arimenda (Alzheimer’s Disease)：市場予測と分析（～2022）Arimenda (Alzheimer’s Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Arimenda (Alzheimer’s Disease) - Forecast and Market Analysis to 2022”. There are no long-term effective therapies for Alzheimer’s Disease (AD), so this remains at the top of the list for unmet needs. While physicians agree that symptomatic therapies ar …
- 世界の航空用ファスナー市場：用途別、材料別、地域別Global Aerospace Fasteners Market: About this market Technavio’s aerospace fasteners market analysis considers sales from aluminum, titanium, superalloys, and steel materials. Our study also finds the sales of aerospace fasteners in APAC, Europe, MEA, North America, and South America. In 2019, the aluminum segment had a significant market share, and this trend is expected to continue over the fore …
- 対話型応答システムの世界市場2016-2020About Interactive Response Systems Interactive response systems, also known as student response systems, audience response systems, and clickers, are a combined package of software and hardware. These systems integrate IT with everyday classroom activities to ensure consistent and seamless interactions during lecture sessions. Technavio’s analysts forecast the global interactive response systems m …
